245 related articles for article (PubMed ID: 17367121)
1. Application of the phosphoramidate ProTide approach to 4'-azidouridine confers sub-micromolar potency versus hepatitis C virus on an inactive nucleoside.
Perrone P; Luoni GM; Kelleher MR; Daverio F; Angell A; Mulready S; Congiatu C; Rajyaguru S; Martin JA; Levêque V; Le Pogam S; Najera I; Klumpp K; Smith DB; McGuigan C
J Med Chem; 2007 Apr; 50(8):1840-9. PubMed ID: 17367121
[TBL] [Abstract][Full Text] [Related]
2. First example of phosphoramidate approach applied to a 4'-substituted purine nucleoside (4'-azidoadenosine): conversion of an inactive nucleoside to a submicromolar compound versus hepatitis C virus.
Perrone P; Daverio F; Valente R; Rajyaguru S; Martin JA; Lévêque V; Le Pogam S; Najera I; Klumpp K; Smith DB; McGuigan C
J Med Chem; 2007 Nov; 50(22):5463-70. PubMed ID: 17914786
[TBL] [Abstract][Full Text] [Related]
3. The application of the phosphoramidate ProTide approach confers micromolar potency against hepatitis C virus on inactive agent 4'-azidoinosine: kinase bypass on a dual base/sugar modified nucleoside.
McGuigan C; Daverio F; Nájera I; Martin JA; Klumpp K; Smith DB
Bioorg Med Chem Lett; 2009 Jun; 19(11):3122-4. PubMed ID: 19398331
[TBL] [Abstract][Full Text] [Related]
4. Phosphoramidate ProTides of 2'-C-methylguanosine as highly potent inhibitors of hepatitis C virus. Study of their in vitro and in vivo properties.
McGuigan C; Gilles A; Madela K; Aljarah M; Holl S; Jones S; Vernachio J; Hutchins J; Ames B; Bryant KD; Gorovits E; Ganguly B; Hunley D; Hall A; Kolykhalov A; Liu Y; Muhammad J; Raja N; Walters R; Wang J; Chamberlain S; Henson G
J Med Chem; 2010 Jul; 53(13):4949-57. PubMed ID: 20527890
[TBL] [Abstract][Full Text] [Related]
5. Application of phosphoramidate ProTide technology significantly improves antiviral potency of carbocyclic adenosine derivatives.
McGuigan C; Hassan-Abdallah A; Srinivasan S; Wang Y; Siddiqui A; Daluge SM; Gudmundsson KS; Zhou H; McLean EW; Peckham JP; Burnette TC; Marr H; Hazen R; Condreay LD; Johnson L; Balzarini J
J Med Chem; 2006 Nov; 49(24):7215-26. PubMed ID: 17125274
[TBL] [Abstract][Full Text] [Related]
6. The phosphoramidate ProTide approach greatly enhances the activity of beta-2'-C-methylguanosine against hepatitis C virus.
McGuigan C; Perrone P; Madela K; Neyts J
Bioorg Med Chem Lett; 2009 Aug; 19(15):4316-20. PubMed ID: 19523820
[TBL] [Abstract][Full Text] [Related]
7. The design, synthesis, and antiviral activity of 4'-azidocytidine analogues against hepatitis C virus replication: the discovery of 4'-azidoarabinocytidine.
Smith DB; Kalayanov G; Sund C; Winqvist A; Pinho P; Maltseva T; Morisson V; Leveque V; Rajyaguru S; Le Pogam S; Najera I; Benkestock K; Zhou XX; Maag H; Cammack N; Martin JA; Swallow S; Johansson NG; Klumpp K; Smith M
J Med Chem; 2009 Jan; 52(1):219-23. PubMed ID: 19055482
[TBL] [Abstract][Full Text] [Related]
8. The application of phosphoramidate ProTide technology to the potent anti-HCV compound 4'-azidocytidine (R1479).
McGuigan C; Kelleher MR; Perrone P; Mulready S; Luoni G; Daverio F; Rajyaguru S; Le Pogam S; Najera I; Martin JA; Klumpp K; Smith DB
Bioorg Med Chem Lett; 2009 Aug; 19(15):4250-4. PubMed ID: 19505826
[TBL] [Abstract][Full Text] [Related]
9. Phosphoramidate prodrugs of 2'-C-methylcytidine for therapy of hepatitis C virus infection.
Gardelli C; Attenni B; Donghi M; Meppen M; Pacini B; Harper S; Di Marco A; Fiore F; Giuliano C; Pucci V; Laufer R; Gennari N; Marcucci I; Leone JF; Olsen DB; MacCoss M; Rowley M; Narjes F
J Med Chem; 2009 Sep; 52(17):5394-407. PubMed ID: 19725579
[TBL] [Abstract][Full Text] [Related]
10. Application of phosphoramidate pronucleotide technology to abacavir leads to a significant enhancement of antiviral potency.
McGuigan C; Harris SA; Daluge SM; Gudmundsson KS; McLean EW; Burnette TC; Marr H; Hazen R; Condreay LD; Johnson L; De Clercq E; Balzarini J
J Med Chem; 2005 May; 48(10):3504-15. PubMed ID: 15887959
[TBL] [Abstract][Full Text] [Related]
11. Dual pro-drugs of 2'-C-methyl guanosine monophosphate as potent and selective inhibitors of hepatitis C virus.
McGuigan C; Madela K; Aljarah M; Gilles A; Battina SK; Ramamurty CV; Srinivas Rao C; Vernachio J; Hutchins J; Hall A; Kolykhalov A; Henson G; Chamberlain S
Bioorg Med Chem Lett; 2011 Oct; 21(19):6007-12. PubMed ID: 21856153
[TBL] [Abstract][Full Text] [Related]
12. 3'-Deoxy phosphoramidate dinucleosides as improved inhibitors of hepatitis C virus subgenomic replicon and NS5B polymerase activity.
Priet S; Zlatev I; Barvik I; Geerts K; Leyssen P; Neyts J; Dutartre H; Canard B; Vasseur JJ; Morvan F; Alvarez K
J Med Chem; 2010 Sep; 53(18):6608-17. PubMed ID: 20799693
[TBL] [Abstract][Full Text] [Related]
13. Phosphorodiamidates as a promising new phosphate prodrug motif for antiviral drug discovery: application to anti-HCV agents.
McGuigan C; Madela K; Aljarah M; Bourdin C; Arrica M; Barrett E; Jones S; Kolykhalov A; Bleiman B; Bryant KD; Ganguly B; Gorovits E; Henson G; Hunley D; Hutchins J; Muhammad J; Obikhod A; Patti J; Walters CR; Wang J; Vernachio J; Ramamurty CV; Battina SK; Chamberlain S
J Med Chem; 2011 Dec; 54(24):8632-45. PubMed ID: 22039920
[TBL] [Abstract][Full Text] [Related]
14. The design, synthesis and antiviral evaluation of a series of 5-trimethylsilyl-1-beta-D-(arabinofuranosyl)uracil phosphoramidate ProTides.
Mehellou Y; Balzarini J; McGuigan C
Antivir Chem Chemother; 2010 Mar; 20(4):153-60. PubMed ID: 20231780
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methylcytidine, a potent inhibitor of hepatitis C virus replication.
Clark JL; Hollecker L; Mason JC; Stuyver LJ; Tharnish PM; Lostia S; McBrayer TR; Schinazi RF; Watanabe KA; Otto MJ; Furman PA; Stec WJ; Patterson SE; Pankiewicz KW
J Med Chem; 2005 Aug; 48(17):5504-8. PubMed ID: 16107149
[TBL] [Abstract][Full Text] [Related]
16. The design, synthesis, and antiviral activity of monofluoro and difluoro analogues of 4'-azidocytidine against hepatitis C virus replication: the discovery of 4'-azido-2'-deoxy-2'-fluorocytidine and 4'-azido-2'-dideoxy-2',2'-difluorocytidine.
Smith DB; Kalayanov G; Sund C; Winqvist A; Maltseva T; Leveque VJ; Rajyaguru S; Le Pogam S; Najera I; Benkestock K; Zhou XX; Kaiser AC; Maag H; Cammack N; Martin JA; Swallow S; Johansson NG; Klumpp K; Smith M
J Med Chem; 2009 May; 52(9):2971-8. PubMed ID: 19341305
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methyl purine nucleosides as inhibitors of hepatitis C virus RNA replication.
Clark JL; Mason JC; Hollecker L; Stuyver LJ; Tharnish PM; McBrayer TR; Otto MJ; Furman PA; Schinazi RF; Watanabe KA
Bioorg Med Chem Lett; 2006 Mar; 16(6):1712-5. PubMed ID: 16368235
[TBL] [Abstract][Full Text] [Related]
18. Diastereoselective synthesis of aryloxy phosphoramidate prodrugs of 3'-deoxy-2',3'-didehydrothymidine monophosphate.
Roman CA; Balzarini J; Meier C
J Med Chem; 2010 Nov; 53(21):7675-81. PubMed ID: 20945915
[TBL] [Abstract][Full Text] [Related]
19. Development of a cell-based assay for high-throughput screening of inhibitors against HCV genotypes 1a and 1b in a single well.
Mondal R; Koev G; Pilot-Matias T; He Y; Ng T; Kati W; Molla A
Antiviral Res; 2009 Apr; 82(1):82-8. PubMed ID: 19174175
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of novel carbocyclic versions of 2'-spirocyclopropyl ribonucleosides as potent anti-HCV agents.
Oh CH; Kim E; Hong JH
Nucleosides Nucleotides Nucleic Acids; 2011 Jun; 30(6):423-39. PubMed ID: 21780908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
